Albany, NY -- (SBWIRE) -- 01/03/2018 -- The utilization of chemoinformatics for the design of new drugs comprises of processing large data, validation of methodologies, and accessing millions of structures. The major driving factors which have driven the growth of the market includes the advancements in the drug development process and use of in-silico techniques. Chemoinformatics allows use of combinatorial chemistry to produce vast number of compounds, molecular modelling to improve drug activity; high throughput screening allowing screening of large number of compounds against a target protein, virtual in-vitro and in-silico models which replaces traditional animal testing models.
As this method is able to predict toxicity and assess the risk associated with it and hence it helps in reduction of animal testing. Based on the wide scope of this technique this can be utilized in the following industries: Pharmaceutical companies, Public organizations, Academic research, Chemical industry etc.
Request Brochure of The Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14315
Based on geography, Chemoinformatics Market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). At present, North America holds a leading position in the market as it observes heavy investments in R&D initiatives, technological expansions and integration of pioneering technologies, major players present in the region, and occurrence of lifestyle related diseases. Europe is followed by North America in the chemoinformatics market due to it is considered as a major hub for geriatrics. Asia Pacific is observed as a growing market due to the increasing research activities and drug development initiative in the region. Many multinational companies are setting up their business base in this region as it aids in low manufacturing and labor cost, less stringent regulations and additionally huge government initiatives which focuses on improvising R&D infrastructure for market growth.
However few factors restrict the growth of this market includes expensive chemoinformatics software and requires huge resources in terms of software and hardware. Different companies store the data in an encoded form and follow their own file formats which could be incompatible with different models. Multinational companies need to develop an international unicode for storage of data. This would enable the database to be globally accepted irrespective of type and location. This unicode will also reduce the duplication of information. Currently, there is a growing need of designing an improved chemoinformatics system which will handle the huge data which is generated from HTS operations.
It is expected that with due course of time, there will be an influx of well-established players in the chemoinformatics market. Some of the key companies operating in the chemoinformatics market are Agilent Technologies, Accelrys Software Inc., OpenEye Scientific, BIOVIA, Bio-Rad Laboratories, Inc. PerkinElmer Inc., Schrödinger, LLC, Chemical Computing Group, Inc., Certara, L.P., The Cambridge Crystallographic Data Centre (CCDC), KNIME.COM AG, EPAM Systems, Scilligence Cambridge Soft ACX, Simulations Plus, Inc., Advanced Chemistry Development, Inc. (ACD/Labs) and ChemAxon, Inc.
Request Discount @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=14315